Basilea wins Swiss marketing approval for eczema drug - Trading Markets (press release)

Sent to you via Google Reader

Basilea wins Swiss marketing approval for eczema drug - Trading Markets (press release)

Basilea wins Swiss marketing approval for eczema drug Trading Markets (press release) Swissmedic approved Toctino for the use in adults who have severe refractory chronic hand eczema that is unresponsive to at least four weeks of extended ... Basilea - Basilea's Toctino® receives marketing authorization in SwitzerlandAd-Hoc-News (Pressemitteilung) Basilea Has No Signs That New Pneumonia Trials NeededWall Street Journal visit: http://www.a1skincareinfo.com

Posted via email from Skin Care Information Resource